Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Phebra Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (108)
Cancellation by sponsor (24)
Section 14, TGO91 consent (16)
Prescription medicine registration (7)
Australian public assessment report (AusPar) (5)
Designation or determination (1)

Date

2025 (12)
2024 (3)
2022 (2)
2021 (1)
2020 (19)
2019 (3)
2018 (3)
2017 (27)
2016 (2)
2015 (1)
2014 (4)
2013 (2)
2012 (3)
2011 (3)
2010 (6)
2009 (6)
2007 (3)
2005 (1)
2004 (2)
2003 (1)
2002 (3)
2001 (1)
2000 (1)
1997 (2)
1994 (5)
1993 (3)
1991 (42)

Search

Sponsor content

161 result(s) found, displaying 51 to 60

METARAMINOL PHEBRA, ARAMINE (Phebra Pty Ltd)

8 December 2017

Prescription medicine registration

Active ingredients: metaraminol (as tartrate).
COLISTIMIXIN PHEBRA colistimethate sodium 1million IU powder for nebuliser solution vial (211398)

2 April 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for COLISTIMIXIN PHEBRA colistimethate sodium 1million IU powder for nebuliser solution vial.
DigiFab Digoxin-specific antibody fragment f(Ab) (ovine) 40mg powder for injection vial (203623)

14 February 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DigiFab Digoxin-specific antibody fragment f(Ab) (ovine) 40mg powder for injection vial.
DBL Methadone Injection BP methadone hydrochloride 10mg/1mL ampoule Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
Methadone Injection BP 10 mg in 1 mL Cancelled under s30(1)(c)

30 June 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
Phebra Pty Ltd - Cryogenic spray, cutaneous (217782)

27 November 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Phebra Pty Ltd - Cryogenic spray, cutaneous.
Fluorescein Sodium Injection 10% Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
TOBRA-DAY 500mg/5mL Injection Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
CAFNEA INJECTION Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
CAFNEA Oral Solution Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.